Search research articles
Contact Us
Filters
Showing results (711-720 of 747) with videos related to
Page
of 75
Sort By:
Plos One
|
March 20, 2010
NADPH oxidase limits innate immune responses in the lungs in mice
Brahm H Segal, Wei Han, Jennifer J Bushey, et al.
Cancer Cell
|
February 5, 2022
Fungal mycobiome drives IL-33 secretion and type 2 immunity in pancreatic cancer
Aftab Alam, Eric Levanduski, Parker Denz, et al.
Cellular & Molecular Immunology
|
January 17, 2024
CD8+ T cell metabolic flexibility elicited by CD28-ARS2 axis-driven alternative splicing of PKM supports antitumor immunity
G Aaron Holling, Colin A Chavel, Anand P Sharda, et al.
Nature
|
June 17, 2026
A distant brown dwarf coplanar to a warm Jupiter and a hot super-Earth
Matías I Jones, Luca Naponiello, Trifon Trifonov, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 5, 2006
Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial
Thomas J Walsh, Issam Raad, Thomas F Patterson, et al.
JCI Insight
|
February 8, 2019
Mature neutrophils suppress T cell immunity in ovarian cancer microenvironment
Kelly L Singel, Tiffany R Emmons, Anm Nazmul H Khan, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
July 14, 2016
Prevention and Treatment of Cancer-Related Infections, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology
Lindsey Robert Baden, Sankar Swaminathan, Michael Angarone, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 10, 2012
Prevention and treatment of cancer-related infections
Lindsey Robert Baden, William Bensinger, Michael Angarone, et al.
Journal of Translational Medicine
|
July 20, 2023
Perspectives in Immunotherapy: meeting report from Immunotherapy Bridge (Naples, November 30th-December 1st, 2022)
Paolo A Ascierto, Antonio Avallone, Carlo Bifulco, et al.
International Journal of Cancer
|
March 7, 2026
TP53 mutation is associated with improved disease control in patients with advanced RAS wild-type colorectal adenocarcinoma treated with cetuximab and pembrolizumab
Christos Fountzilas, Spencer Rosario, Agnieszka K Witkiewicz, et al.
Page
of 75
Search research articles
Search
Showing results (711-720 of 747) with videos related to
Sort By:
Page
of 75
Plos One
|
March 20, 2010
NADPH oxidase limits innate immune responses in the lungs in mice
Brahm H Segal, Wei Han, Jennifer J Bushey, et al.
Cancer Cell
|
February 5, 2022
Fungal mycobiome drives IL-33 secretion and type 2 immunity in pancreatic cancer
Aftab Alam, Eric Levanduski, Parker Denz, et al.
Cellular & Molecular Immunology
|
January 17, 2024
CD8+ T cell metabolic flexibility elicited by CD28-ARS2 axis-driven alternative splicing of PKM supports antitumor immunity
G Aaron Holling, Colin A Chavel, Anand P Sharda, et al.
Nature
|
June 17, 2026
A distant brown dwarf coplanar to a warm Jupiter and a hot super-Earth
Matías I Jones, Luca Naponiello, Trifon Trifonov, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 5, 2006
Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial
Thomas J Walsh, Issam Raad, Thomas F Patterson, et al.
JCI Insight
|
February 8, 2019
Mature neutrophils suppress T cell immunity in ovarian cancer microenvironment
Kelly L Singel, Tiffany R Emmons, Anm Nazmul H Khan, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
July 14, 2016
Prevention and Treatment of Cancer-Related Infections, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology
Lindsey Robert Baden, Sankar Swaminathan, Michael Angarone, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 10, 2012
Prevention and treatment of cancer-related infections
Lindsey Robert Baden, William Bensinger, Michael Angarone, et al.
Journal of Translational Medicine
|
July 20, 2023
Perspectives in Immunotherapy: meeting report from Immunotherapy Bridge (Naples, November 30th-December 1st, 2022)
Paolo A Ascierto, Antonio Avallone, Carlo Bifulco, et al.
International Journal of Cancer
|
March 7, 2026
TP53 mutation is associated with improved disease control in patients with advanced RAS wild-type colorectal adenocarcinoma treated with cetuximab and pembrolizumab
Christos Fountzilas, Spencer Rosario, Agnieszka K Witkiewicz, et al.
Page
of 75